Latest articles for Major Depressive Disorder
From the Journals
CRP levels could predict SSRI success
SSRIs were less effective in depressed patients with high C-reactive protein levels than in those with low levels.
From the Journals
A ‘setback’ for anti-inflammatory treatment in depression
Study results showed minocycline was well tolerated but was not superior to placebo in reducing depressive symptoms.
Latest News
Eighty percent of U.S. maternal deaths are preventable: Study
“It’s significant. It’s staggering. It’s heartbreaking.”
From the Journals
Ketamine linked to reduced suicidal thoughts, depression, anxiety
Sex, age, and other demographic characteristics did not predict response or remission, but suicide planning trended toward higher response rates...
Commentary
Depression as a terminal illness
Suicide is often viewed as a symptom of severe depression, but what if we considered death as part of the disease process itself?
From the Journals
Borderline personality disorder raises relapse risk for MDD patients after ECT
Better BPD screening may improve outcomes for depressed patients undergoing electroconvulsive therapy.
From the Journals
Brief Psychiatric Rating Scale succeeds as transdiagnostic measure
The BPRS showed solid correlation with the mini-ICF-APP for disorders in six different categories.
FDA/CDC
FDA approves ‘rapid-acting’ oral drug for major depression
It is the "first and only rapid-acting oral medicine approved for the treatment of MDD.
Latest News
Postpartum depression risk higher with family psych history
The risk for PPD was almost twice as high for mothers who have any psychiatric disorder in their family history compared with mothers who don’t....
Conference Coverage
What ketamine and psilocybin can and cannot do in depression
While ketamine is only suitable for acute intervention, owing to the short duration of effect, the effects of psilocybin can last for weeks or...